We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us

Download Mobile App


ATTENTION: Due to the COVID-19 PANDEMIC, many events are being rescheduled for a later date, converted into virtual venues, or altogether cancelled. Please check with the event organizer or website prior to planning for any forthcoming event.
23 Jan 2021 - 27 Jan 2021
Virtual Venue
24 Feb 2021 - 28 Feb 2021
Virtual Venue



Thermo Fisher Acquires Point-of-Care Molecular Diagnostics Provider Mesa Biotech

Thermo Fisher Scientific Inc. (Waltham, MA, USA) has entered into a definitive agreement to acquire Mesa Biotech (San Diego, CA, USA), a privately held molecular diagnostic company, for approximately USD 450 million in cash. More...
20 Jan 2021
Image: uPath HER2 Dual ISH image analysis for breast cancer (Photo courtesy of Roche)

Roche Launches Digital Pathology Image Analysis Algorithms for Precision Patient Diagnosis in Breast Cancer

Roche (Basel, Switzerland) has announced the CE-IVD launch of its automated digital pathology algorithms, uPath HER2 (4B5) image analysis and uPath Dual ISH image analysis for breast cancer to help determine the best treatment strategy for each patient. More...
13 Jan 2021

PerkinElmer to Acquire Oxford Immunotec Global PLC

PerkinElmer, Inc. (Waltham, MA; USA) has reached an agreement to acquire Oxford Immunotec Ltd. (Abingdon, UK) that will allow the company to grow its portfolio of advanced infectious disease testing solutions to include tuberculosis detection. More...
08 Jan 2021
Image: iModules Integration System for Immunoassay (Photo courtesy of Shenzhen YHLO Biotech Co., Ltd.)

YHLO Helps China’s Top Ranking Hospital PUMCH to Upgrade from Traditional ELISA to CLIA Technology

Shenzhen YHLO Biotech Co., Ltd. (Shenzhen, China) has helped China’s top ranking hospital, Peking Union Medical College Hospital (PUMCH; Beijing, China), to successfully upgrade its laboratory from the traditional ELISA (enzyme-linked immunoassay) technology to CLIA (chemiluminescence immunoassay) technology. More...
06 Jan 2021

COVID-19 Diagnostics Market to Surpass Revenues of USD 13 Billion in 2020

The global COVID-19 diagnostics market is expected to reach revenues of over USD 13 billion in 2020 and is projected to grow at a CAGR of around (9)% during the period 2020-2026, driven by the surging demand for rapid testing across the globe. However, once COVID-19 vaccines are released in the market, the novel coronavirus will no longer be given pandemic status and COVID-19 will become like any other normal infectious disease, thus reducing the demand for test kits in the market. More...
10 Dec 2020

Global Viral RNA Extraction Kit Market to Continue Being Driven by COVID-19 Pandemic

The global viral RNA extraction kit market is projected to record significant growth in the years to come, driven by the ongoing COVID-19 pandemic as a number of biotech companies race against time to come up with a coronavirus vaccine. More...
08 Dec 2020
Image: Nova Primary analyzer (Photo courtesy of Nova Biomedical)

Nova Biomedical Launches New Laboratory Blood Glucose Reference Analyzer

Nova Biomedical (Waltham, MA, USA) has launched Nova Primary, a rapid, accurate, easy to use, blood glucose laboratory analyzer that fills the need for a new glucose reference analyzer to replace the YSI STAT PLUS 2300 Glucose and L-Lactate analyzer from YSI, Inc., (Yellow Springs, OH, USA). More...
19 Nov 2020

LabMedica Industry News channel reports on mergers and takeovers, on cooperative agreements and on trends in the IVD industry worldwide.
Copyright © 2000-2021 Globetech Media. All rights reserved.